温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 1 月 9 日）- Burcon NutraScience Corporation（多伦多证券交易所代码：BU）（OTCQB 代码：BRCNF）（&#34; Burcon&#34; 或 &#34; 公司&#34;），作为全球植物基蛋白创新的技术领导者，欣然宣布，鉴于强劲的需求，已将其之前宣布的非承销私人配售（&#34;私人配售&#34;）的可转换债券（&#34;可转换债券&#34;）的总本金金额增加至最高 690 万美元。有关更多细节，请参阅公司于 2026 年 1 月 2 日发布的新闻稿。
&#34;在一个充满挑战的市场中，我们对投资者的强烈兴趣感到鼓舞，&#34; Burcon 首席执行官 Kip Underwood 表示。&#34;在内部人士和主要股东的持续支持下，我们正在加快生产和销售时间表，并重申我们 2026 年日历年的收入目标超过 1000 万美元。&#34;
公司的内部人士和 Burcon 的制造合作伙伴所有者承诺至少参与 500 万美元的本金金额。私人配售已获得多伦多证券交易所（&#34;TSX&#34;）的有条件批准，前提是 Burcon 遵守该有条件批准的条款，包括获得无利益相关股东的批准。
关于 Burcon NutraScience Corporation
Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖从豌豆、油菜、黄豆、麻、向日葵和其他植物来源提取的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。
前瞻性信息警示声明
TSX 未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性声明或前瞻性信息，包括与内部人士参与私人配售相关的声明。前瞻性声明或前瞻性信息涉及风险、不确定性和其他因素，这些因素可能导致实际结果、表现、前景和机会与这些前瞻性声明所表达或暗示的结果有实质性差异。前瞻性声明或前瞻性信息可以通过诸如&#34;预期&#34;、&#34;目标&#34;、&#34;意图&#34;、&#34;计划&#34;、&#34;目标&#34;、&#34;项目&#34;、&#34;估计&#34;、&#34;期望&#34;、&#34;相信&#34;、&#34;未来&#34;、&#34;可能&#34;、&#34;应&#34;、&#34;可以&#34;、&#34;将&#34;及类似的未来时期的参考词来识别。除历史事实的陈述外，本发布中包含的所有声明均为前瞻性声明。不能保证这些声明将被证明是准确的，实际结果和未来事件可能与这些声明或信息中预期的结果有实质性差异。可能导致实际结果与 Burcon 的计划和预期有实质性差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和经营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及其他风险和因素，详见 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的&#34;风险因素&#34;部分及其在 SEDAR+ 上向加拿大证券监管机构的其他公开文件 www.sedarplus.ca。此列表并非详尽无遗，可能影响公司任何前瞻性声明或信息的因素。任何前瞻性声明或信息仅在作出之日有效，除非适用的证券法要求，否则 Burcon 不承担更新任何前瞻性声明的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 相信前瞻性声明中固有的假设是合理的，但前瞻性声明并不保证未来的表现，因此，投资者不应依赖这些声明。
<img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/279895_28ad27eb24e6ca6f_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/279895_28ad27eb24e6ca6f_logo.jpg"/>
要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/279895
<img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/279895/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/279895/375"/>

BRCNF

Burcon NutraScience Corporation 因投资者需求强劲，将其非承销可转换债券的私人配售金额增加至 690 万美元。首席执行官 Kip Underwood 对公司 2026 年超过 1000 万美元的收入目标表示乐观，并得到了至少 500 万美元的内部参与支持。该配售已获得多伦多证券交易所的有条件批准，待符合条款和股东批准。Burcon 专注于植物基蛋白创新，并在该领域拥有重要的专利组合

Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (&#34; Burcon&#34; or the &#34; Company&#34;), a global technology leader in plant-based protein innovation, is pleased to announce that, in response to strong demand, it has increased the size of its previously announced non-brokered private placement (the &#34;Private Placement&#34;) of convertible debentures (the &#34;Convertible Debentures&#34;) to an aggregate principal amount of up to $6.9 million. For additional details, please refer to the Company's news release dated January 2, 2026.
<div class="lb-trans">温哥华，不列颠哥伦比亚省 --（Newsfile Corp. -2026 年 1 月 9 日）- Burcon NutraScience Corporation（多伦多证券交易所代码：BU）（OTCQB 代码：BRCNF）（&#34; Burcon&#34; 或 &#34; 公司&#34;），作为全球植物基蛋白创新的技术领导者，欣然宣布，鉴于强劲的需求，已将其之前宣布的非承销私人配售（&#34;私人配售&#34;）的可转换债券（&#34;可转换债券&#34;）的总本金金额增加至最高 690 万美元。有关更多细节，请参阅公司于 2026 年 1 月 2 日发布的新闻稿。
</div>&#34;We are encouraged by the strong investor interest in a challenging market,&#34; said Kip Underwood, Burcon's chief executive officer. &#34;With continued support from insiders and major shareholders, we are accelerating our production and sales timeline and reaffirm our revenue target of more than $10 million for calendar 2026.&#34;
<div class="lb-trans">&#34;在一个充满挑战的市场中，我们对投资者的强烈兴趣感到鼓舞，&#34; Burcon 首席执行官 Kip Underwood 表示。&#34;在内部人士和主要股东的持续支持下，我们正在加快生产和销售时间表，并重申我们 2026 年日历年的收入目标超过 1000 万美元。&#34;
</div>Insiders of the Company and Burcon's manufacturing partner owners are committed to participating at a minimum of $5.0 million in principal amount. The Private Placement has been conditionally approved by the Toronto Stock Exchange (&#34;TSX&#34;) subject to Burcon complying with the terms of such conditional approval, including receipt of disinterested shareholder approval.
<div class="lb-trans">公司的内部人士和 Burcon 的制造合作伙伴所有者承诺至少参与 500 万美元的本金金额。私人配售已获得多伦多证券交易所（&#34;TSX&#34;）的有条件批准，前提是 Burcon 遵守该有条件批准的条款，包括获得无利益相关股东的批准。
</div>About Burcon NutraScience Corporation
<div class="lb-trans">关于 Burcon NutraScience Corporation
</div>Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.
<div class="lb-trans">Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖从豌豆、油菜、黄豆、麻、向日葵和其他植物来源提取的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。
</div>Forward-Looking Information Cautionary Statement
<div class="lb-trans">前瞻性信息警示声明
</div>The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, including statements relating to insider participation in the private placement. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as &#34;anticipate,&#34; &#34;aim&#34;, &#34;intend,&#34; &#34;plan,&#34; &#34;goal,&#34; &#34;project,&#34; &#34;estimate,&#34; &#34;expect,&#34; &#34;believe,&#34; &#34;future,&#34; &#34;likely,&#34; &#34;may,&#34; &#34;should,&#34; &#34;could,&#34; &#34;will&#34; and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled &#34;Risk Factors&#34; in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
<div class="lb-trans">TSX 未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性声明或前瞻性信息，包括与内部人士参与私人配售相关的声明。前瞻性声明或前瞻性信息涉及风险、不确定性和其他因素，这些因素可能导致实际结果、表现、前景和机会与这些前瞻性声明所表达或暗示的结果有实质性差异。前瞻性声明或前瞻性信息可以通过诸如&#34;预期&#34;、&#34;目标&#34;、&#34;意图&#34;、&#34;计划&#34;、&#34;目标&#34;、&#34;项目&#34;、&#34;估计&#34;、&#34;期望&#34;、&#34;相信&#34;、&#34;未来&#34;、&#34;可能&#34;、&#34;应&#34;、&#34;可以&#34;、&#34;将&#34;及类似的未来时期的参考词来识别。除历史事实的陈述外，本发布中包含的所有声明均为前瞻性声明。不能保证这些声明将被证明是准确的，实际结果和未来事件可能与这些声明或信息中预期的结果有实质性差异。可能导致实际结果与 Burcon 的计划和预期有实质性差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和经营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及其他风险和因素，详见 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的&#34;风险因素&#34;部分及其在 SEDAR+ 上向加拿大证券监管机构的其他公开文件 www.sedarplus.ca。此列表并非详尽无遗，可能影响公司任何前瞻性声明或信息的因素。任何前瞻性声明或信息仅在作出之日有效，除非适用的证券法要求，否则 Burcon 不承担更新任何前瞻性声明的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 相信前瞻性声明中固有的假设是合理的，但前瞻性声明并不保证未来的表现，因此，投资者不应依赖这些声明。
</div><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/279895_28ad27eb24e6ca6f_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/1725/279895_28ad27eb24e6ca6f_logo.jpg"/>
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279895
<div class="lb-trans">要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/279895
</div><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/279895/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/279895/375"/>

Burcon 将非经纪可转换债券的私人配售金额增加至 690 万美元 | BRCNF 股票新闻